Skip to main content

Advertisement

Table 2 Rates of EGFR exon 21 mutation

From: Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level

Patient no. Cells number Mutation rate P-value
Long PFS group 0.021
 No.1 19 17 (89.5%)
 No.2 21 17 (81.0%)
 No.3 19 17 (89.5%)
 Total 59 51 (86.4%)
Short PFS group
 No.4 18 13 (72.2%)
 No.5 21 14 (66.7%)
 No.6 22 15 (68.2%)
 Total 61 42 (68.9%)